colchicine binding site-targeting microtubule inhibitor (BridGene Biosciences/University of Tennessee)

N/A

Report date: 2025/06/11 11:07:14
NME

Base Information

Drug Namecolchicine binding site-targeting microtubule inhibitor (BridGene Biosciences/University of Tennessee)
Drug Alias Namemicrotubule inhibitor (BridGene Biosciences/University of Tennessee)
ClassificationSmall molecules
Mechanisms of ActionMicrotubule inhibitors
TargetsUpdating
Therapy Area/IndicationsMetastatic breast cancerTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Tennessee Health Science Center
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Tennessee Health Science CenterBridGene Biosciences Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A